Similar articles

• Experimental model systems for antibody targeting and radioimmunodetection.

  Blumenthal RD, Sharkey RM, Goldenberg DM. Blumenthal RD, et al. Cancer Treat Res. 1990;51:29-52. doi: 10.1007/978-1-4613-1497-4_3. Cancer Treat Res. 1990. PMID: 1977450 Review. No abstract available.
• Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies.

  Buchsbaum DJ, Brubaker PG, Hanna DE, Glatfelter AA, Terry VH, Guilbault DM, Steplewski Z. Buchsbaum DJ, et al. Cancer Res. 1990 Feb 1;50(3 Suppl):993s-999s. Cancer Res. 1990. PMID: 2297753
• Generation and application of monoclonal antibody to human pancreatic carcinoma.

  Yuan S, Zhang H, Chen Q. Yuan S, et al. Hybridoma. 1996 Aug;15(4):289-93. doi: 10.1089/hyb.1996.15.289. Hybridoma. 1996. PMID: 8880216
• 131I-labelled tumour-specific antibodies: trial to concentrate radioisotopes specifically in tumours. 3. Improved radioimaging and tumour localization in nude mice with a monoclonal anti-CEA antibody by preincubation of labelled antibody with syngeneic spleen cells. (A rapid communication).

  Makidono R, Ayabe Z, Matsuura K, Shiozaki H, Makidono A. Makidono R, et al. Nihon Igaku Hoshasen Gakkai Zasshi. 1985 Feb 25;45(2):388-92. Nihon Igaku Hoshasen Gakkai Zasshi. 1985. PMID: 4011413 No abstract available.
• Carcinoembryonic antigen as a target cancer antigen for radiolabeled antibodies: prospects for cancer imaging and therapy.

  Goldenberg DM. Goldenberg DM. Tumour Biol. 1995;16(1):62-73. doi: 10.1159/000217930. Tumour Biol. 1995. PMID: 7863224 Review.